FGFR 1 HIGH AMPLIFICATION

Clinical trials for FGFR 1 HIGH AMPLIFICATION explained in plain language.

Never miss a new study

Get alerted when new FGFR 1 HIGH AMPLIFICATION trials appear

Sign up with your email to follow new studies for FGFR 1 HIGH AMPLIFICATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Targeted therapy tested for Tough-to-Treat breast cancer

Disease control Terminated

This study tested a drug called futibatinib, alone or with hormone therapy, for people with advanced breast cancer that had spread and had specific genetic changes (FGFR gene amplifications). The goal was to see if the treatment could shrink tumors or control the cancer's growth.…

Matched conditions: FGFR 1 HIGH AMPLIFICATION

Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

FGFR 1 HIGH AMPLIFICATION

Get alerted when new FGFR 1 HIGH AMPLIFICATION trials appear

Targeted therapy tested for Tough-to-Treat breast cancer